Abstract
Functional avidity is supposed to critically shape the quality of immune responses, thereby influencing host protection against infectious agents including SARS-CoV-2. Here we show that after human SARS-CoV-2 vaccination, a large portion of high-avidity spike-specific CD4+ T cells lost CD3 expression after in vitro activation. The CD3– subset was enriched for cytokine-positive cells, including elevated per-cell expression levels, and showed increased polyfunctionality. Assessment of key metabolic pathways by flow cytometry revealed that superior functionality was accompanied by a shift toward fatty acid synthesis at the expense of their oxidation, whereas glucose transport and glycolysis were similarly regulated in SARS-CoV-2–specific CD3– and CD3+ subsets. As opposed to their CD3+ counterparts, frequencies of vaccine-specific CD3– T cells positively correlated with both the size of the naive CD4+ T cell pool and vaccine-specific IgG levels. Moreover, their frequencies negatively correlated with advancing age and were impaired in patients under immunosuppressive therapy. Typical recall antigen–reactive T cells showed a comparable segregation into functionally and metabolically distinct CD3+ and CD3– subsets but were quantitatively maintained upon aging, likely due to earlier recruitment in life. In summary, our data identify CD3– T helper cells as correlates of high-quality immune responses that are impaired in at-risk populations.
Authors
Arne Sattler, Stefanie Gamradt, Vanessa Proß, Linda Marie Laura Thole, An He, Eva Vanessa Schrezenmeier, Katharina Jechow, Stefan M. Gold, Sören Lukassen, Christian Conrad, Katja Kotsch
Figure 7
Vaccine-specific CD3–CD4+ Th cells in patients on dialysis and kidney transplant recipients.
